KRISTIN LAMAY: Open Payments
NPI 1164855243 · OGDENSBURG, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,312 in 69 payments from 18 companies in 2025. Trend: 2023 $1,382 · 2024 $1,332 · 2025 $1,312
Food & beverage: $1,312
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $453 |
| Novo Nordisk Inc | 10 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $108 |
| Lilly USA, LLC | 4 | $75 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Exact Sciences Corporation | 4 | $69 |
| PFIZER INC. | 3 | $65 |
| ABBVIE INC. | 3 | $53 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
Products named: FARXIGA, AIRSUPRA, CAPLYTA, Wegovy, MOUNJARO, TRELEGY ELLIPTA, Ozempic, BREZTRI.
Industry payments across NY — which companies pay providers there.
